Should we maximise QALYs? A debate with respect to peak-end evaluation

Applied Health Economics and Health Policy

Volumn 3, Issue 2, 2004, Pages 61-66

  Oliver, Adam ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE; HEALTH CARE POLICY; HEALTH ECONOMICS; HEALTH STATUS; MEDICAL DECISION MAKING; MEDICAL LITERATURE; OUTCOMES RESEARCH; REVIEW;

COST-BENEFIT ANALYSIS; HEALTH PRIORITIES; HUMANS; QUALITY-ADJUSTED LIFE YEARS;

EID: 22544451869     PISSN: 11755652     EISSN: 11755652     Source Type: Journal    
DOI: 10.2165/00148365-200403020-00001     Document Type: Review

References (29)

1. Ministry of Health. Ontario guidelines for economic analysis of pharmaceutical products. Toronto: Ministry of Health, 1994
2. Commonwealth of Australia. Guidelines for the pharmaceutical industry on preparation of submissions to the pharmaceutical benefits advisory committee: including submissions involving economic analyses. Canberra: Australian Government Printing Office, 1995
3. Norwegian Medicines Control Authority. Norwegian guidelines for pharmaco-economic analysis in connection with application for reimbursement. Oslo: Norwegian Medicines Control Authority (SLK), 1999
4. Sickness Funds Council. Dutch guidelines for pharmacoeconomic research. Amtelveen: Ziekenfondsraad, 1999
5. Carlsson P. Health technology assessment and priority setting for health policy in Sweden. Int J Technol Assess Health Care 2004; 20: 44-54
6. Stevens A, Milne R. Health technology assessment in England and Wales. Int J Technol Assess Health Care 2004; 20: 11-24
7. Williams A. Economics of coronary artery bypass grafting. BMJ 1985; 291: 326-9
8. National Institute for Clinical Excellence [NICE]. Technical guidance for manufacturers and sponsors on making a submission to a technology appraisal. London: NICE, 2001
9. Donaldson C, Shackley P. Willingness to pay for health care. In: Scott A, Maynard A, Elliot R, editors. Advances in health economics. Chichester: John Wiley and Sons, 2002
10. Cookson R. Willingness to pay methods in health care: a sceptical view. Health Econ 2003; 12: 891-4
11. Oliver A. Putting the quality into quality-adjusted life years. J Public Health Med 2003 Mar; 25: 8-12
12. Loomes G, McKenzie L. The use of QALYs in health care decision-making. Soc Sci Med 1989; 28: 299-308
13. von Neumann J, Morgenstern O. Theory of games and economic behavior. Princeton: Princeton University Press, 1944
14. Camerer C. Individual decision making. In: Kagel JH, Roth AE, editors. The handbook of experimental economics. Princeton: Princeton University Press, 1995
15. Kahneman D, Wakker PP, Sarin R. Back to Bentham? Explorations of expected utility. Q J Econ 1997; 112: 375-405
16. Bentham J. An introduction to the principles of morals and legislations. Oxford: Blackwell, 1948 [originally published in 1789]
17. Mill JS. Utilitarianism. Glasgow: William Collins, 1962 [originally published in 1861]
18. Fredrickson BL, Kahneman D. Duration neglect in retrospective evaluations of affective episodes. J Pers Soc Psychol 1993; 65: 45-55
19. Redelmeier D, Kahneman D. Patients' memories of painful medical treatments: real-time and retrospective evaluations of two minimally invasive procedures. Pain 1996; 66: 3-8
20. Redelmeier D, Katz J, Kahneman D. Memories of colonoscopy: a randomised trial. Pain 2003; 104: 187-94
21. Ariely D, Carmon Z. Gestalt characteristics of experiences: the defining features of summarized events. J Behav Decis Making 2000; 13: 191-201
22. Kahneman D, Fredrickson BL, Schreiber CA, et al. When more pain is preferred to less: adding a better end. Psychol Sci 1993; 4: 401-5
23. Schreiber CA, Kahneman D. Determinants of the remembered utility of aversive sounds. J Exp Psychol Gen 2000; 129: 27-42
24. Ariely D, Loewenstein G. When does duration matter in judgment and decision making? J Exp Psychol Gen 2000; 129: 508-29
25. Diener E, Wirtz D, Oishi S. End effects of rated life quality: the James Dean effect. Psychol Sci 2001; 12: 124-8
26. Macran S, Kind P. 'Death' and the valuation of health-related quality of life. Med Decis Making 2001; 39: 217-27
27. Mowrer OH, Solomon LN. Contiguity vs drive-reduction in conditioned fear: the proximity and abruptness of drive-reduction. Am J Psychol 1954; 67: 15-25
28. Le Grand J. Motivation, agency, and public policy: of knights and knaves, pawns and queens. Oxford: Oxford University Press, 2003
29. Oliver A, editor. Equity in health and healthcare: views from ethics, economics and political science. London: The Nuffield Trust, 2003